Trualt Bioenergy Announces Board Meeting to Approve Q1 Financial Results
Trualt Bioenergy Ltd has scheduled a meeting of its Board of Directors to review and approve the unaudited financial results for the quarter ended June 30, 2026.The Board meeting is set for Tuesday, July 28, 2026. The primary agenda item for the meeting includes considering and approving both the Standalone and Consolidated Financial Results of the company for the specified quarter.
In continuation of previous notifications regarding insider trading regulations, the company confirmed that the trading window remains closed for all designated persons and their immediate relatives. This restricted period will remain in effect until 48 hours following the submission of the unaudited (Standalone and Consolidated) Financial Results to the Stock Exchanges.
TRUALT Stock Price Movement
Shares of TruAlt Bioenergy Limited today slipped by 0.90%, settling at ₹428.95 in the post-market session. The stock recorded a trading volume of 287,154 shares and remained within its intraday range after dipping toward a low of ₹426.5.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.